These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23862208)

  • 1. Ask the doctor. I have chronic diarrhea because of irritable bowel syndrome (IBS). Should I take probiotics?
    Robb-Nicholson C
    Harv Womens Health Watch; 2013 Mar; 20(7):2. PubMed ID: 23862208
    [No Abstract]   [Full Text] [Related]  

  • 2. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.
    Sohn W; Lee OY; Kwon JG; Park KS; Lim YJ; Kim TH; Jung SW; Kim JI
    Neurogastroenterol Motil; 2012 Sep; 24(9):860-e398. PubMed ID: 22679908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for probiotics in irritable bowel syndrome?
    Camilleri M
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S266-9. PubMed ID: 17259088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
    Bleser S
    Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of probiotics in the pediatric population.
    Wallace B
    Nutr Clin Pract; 2009; 24(1):50-9. PubMed ID: 19244149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing irritable bowel syndrome without special drugs. Another IBS drug has been taken off the market because of serious side effects. Now what?
    Harv Womens Health Watch; 2007 Jun; 14(10):3-4. PubMed ID: 18018315
    [No Abstract]   [Full Text] [Related]  

  • 11. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
    Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
    Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics and the irritable bowel syndrome.
    Chassany O; Matuchansky C
    Aliment Pharmacol Ther; 2008 Apr; 27(7):616-7; author reply 617-8. PubMed ID: 18194493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical efficacy of Actimel for patients with the irritated bowel syndrome with prevailing diarrhea].
    Parfenov AI; Ruchkina IN; Tsaregorodtsev TM; Serova TI
    Eksp Klin Gastroenterol; 2005; (5):45-52. PubMed ID: 16518915
    [No Abstract]   [Full Text] [Related]  

  • 16. Probiotics and digestive disease.
    Mullin GE
    Nutr Clin Pract; 2012 Apr; 27(2):300-2. PubMed ID: 22367887
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome.
    Malone MA
    Prim Care; 2011 Sep; 38(3):433-47; viii. PubMed ID: 21872090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
    Ford AC; Talley NJ; Quigley EM; Moayyedi P
    Dis Colon Rectum; 2009 Oct; 52(10):1805; author reply 1806. PubMed ID: 19966623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.